Impact of performance status and age on osimertinib efficacy in patients with
EGFR
-mutant T790M-positive non-small-cell lung cancer
J Thorac Dis
.
2019 Sep;11(Suppl 15):S1831-S1834.
doi: 10.21037/jtd.2019.08.104.
Authors
Giuseppe Lamberti
1
,
Elisa Andrini
1
,
Biagio Ricciuti
2
Affiliations
1
Department of Specialized, Experimental and Diagnostic Medicine, Policlinico S.Orsola-Malpighi, University of Bologna, Bologna, Italy.
2
Thoracic Oncology Unit, Santa Maria della Misericordia Hospital, University of Perugia, Piazzale Menghini, Perugia, Italy.
PMID:
31632761
PMCID:
PMC6783754
DOI:
10.21037/jtd.2019.08.104
No abstract available
Publication types
Editorial
Comment